The emergence of new variants of the SARS-CoV-2 virus poses ongoing challenges. Epidemiologists conduct genomic surveillance to detect and track variants, assess their transmissibility, and evaluate the effectiveness of existing vaccines against them. This information is critical for updating public health guidelines and vaccine formulations.
